What's new

Orphan designation: recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1 Treatment of calciphylaxis, 22/05/2025 Positive

Orphan designation: recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1 Treatment of calciphylaxis, 22/05/2025 Positive

Jun 24, 2025 - 19:10
 0
Orphan designation: recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1 Treatment of calciphylaxis, 22/05/2025 Positive
Orphan designation: recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1 Treatment of calciphylaxis, 22/05/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/...

Next Article

In a Changing Middle East, What Role Do Iran’s Partners Play?

Related Posts

Process for the electronic submission of medicinal prod...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Nyxoid, naloxone, Date of authorisation: 09/11/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

European Shortages Monitoring Platform (ESMP) essential...

May 13, 2025  0